MBOT Novinky na Forexe
Microbot Medical Announces Positive Results For GLP Pivotal Pre-Clinical Study; Stock Up 15%
Microbot Medical Inc. (MBOT) announced Thursday the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels of planning, controlling, monitoring, and reporting, using a porcine model.
RTTNews
|
Pred 1007 dňami
